Shares of Affymax AFFY are lower on the session by 1.24%, trading at $3.99.
Overall call volume is now running at 9.89x the daily average, with 1% of all calls traded being purchases on the offer. 3,115 contracts have traded on the session so far.
Affymax, Inc. is a biopharmaceutical company developing drugs to improve the treatment of serious and often life-threatening conditions.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in